Qinghai Spring Medicinal Resources Technology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Xuefeng Zhang
Chief executive officer
CN¥625.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.8yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Optimistic Investors Push Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) Shares Up 25% But Growth Is Lacking
Jan 16
There's Reason For Concern Over Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Massive 30% Price Jump
Nov 11Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump
Jun 24Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues
May 09Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues
Mar 12CEO
Xuefeng Zhang (54 yo)
9.8yrs
Tenure
CN¥625,600
Compensation
Mr. Xuefeng Zhang serves as Chairman & GM of Qinghai Spring Medicinal Resources Technology Co., Ltd. since May 15, 2015.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 9.8yrs | CN¥625.60k | no data | |
| Independent Director | 4.7yrs | CN¥60.00k | no data | |
| Supervisor | 2.8yrs | no data | no data | |
| Independent Director | 1.8yrs | no data | no data |
3.7yrs
Average Tenure
55yo
Average Age
Experienced Board: 600381's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 09:25 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Qinghai Spring Medicinal Resources Technology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Qi He | Huatai Research |